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Differentiation of CD41 T Cells to Th1 Cells
Requires MAP Kinase JNK2
the immune system. During this differentiation process,
substantial reprogramming of gene expression occurs.
Two subsets of effector Th cells have been defined
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1993). IL-12 is secreted by APC, while IFNg is initially
secreted by natural killer (NK) cells and by the Th1 cells
themselves during their differentiation. APC-derived IL-6
Summary has been found to polarize Th2 differentiation by induc-
ing the initial production of IL-4 in naive CD41 T cells
Precursor CD41 T cells develop into effector Th1 and (RincoÂ n et al., 1997a).
Th2 cells that play a central role in the immune re- Recent studies have implicated MAP kinase signaling
sponse. We show that the JNK MAP kinase pathway pathways in the control of the immune response (Whit-
is induced in Th1 but not in Th2 effector cells upon marsh and Davis, 1996; Ip and Davis, 1998). These sig-
antigen stimulation. Further, the differentiation of pre- naling pathways include those leading to the activation
cursor CD41 T cells into effector Th1 but not Th2 cells of the extracellular signal-regulated kinases (ERK), c-Jun
is impaired in JNK2-deficient mice. The inability of IL- amino terminal kinases (JNK, also known as SAPK), and
12 to differentiate JNK2-deficient CD41 T cells fully p38 MAP kinases. Although many studies have ad-
into effector Th1 cells is caused by a defect in IFNg dressed the regulation of these pathways during T cell
production during the early stages of differentiation. activation and/or differentiation, the specific role of
The addition of exogenous IFNg during differentiation these MAP kinase signaling pathways is not yet under-
restores IL-12-mediated Th1 polarization in the JNK2- stood. Both JNK and ERK are activated following T cell
deficient mice. The JNK MAP kinase signaling path- stimulation. Inhibition of the ERK pathway in transgenic
way, therefore, plays an important role in the balance mice does not significantly affect mature T cell prolifera-
of Th1 and Th2 immune responses. tion (Alberola-Ila et al., 1995). While a TCR-mediated
signal is sufficient to activate the ERK pathway, an addi-
tional costimulatory signal mediated by CD28 is required
Introduction to induce JNK activity (Su et al., 1994). A costimulatory
signal is also required in precursor T cells for activation
Naive (precursor) CD41 helper T (Th) cells recognize of the JNK substrate AP-1/c-Jun (RincoÂ n and Flavell,
specific MHC-peptide complexes on antigen-presenting 1994). Mice deficient for the MAP kinase kinase SEK1/
cells (APC) via the T cell receptor (TCR) complex. In MKK (a JNK activator) display somewhat decreased
addition to the TCR-mediated signal, a costimulatory CD3/CD28-mediated T cell proliferation (Nishina et al.,
signal is provided at least partially by the ligation of 1997; Swat et al., 1998). A new MAP kinase kinase,
CD28 expressed on T cells with B7 proteins on APC MKK7, which phosphorylates and activates JNK, has
(Linsley and Ledbetter, 1993). The combination of these recently been identified (Tournier et al., 1997), but the
two signals induces T cell clonal expansion. After 4±5 regulation of this kinase in T cells has not been de-
days of proliferation, precursor CD41 T cells differentiate scribed. Thus, the specific role of the JNK pathway in
into armed effector Th cells that mediate the functions of the activation and differentiation of precursor CD41 T
cells remains unclear.
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gene results in the abrogation of neuronal apoptosis in# Present address: Lilly Research Laboratories, Lilly Corporate Cen-
ter, Indianapolis, Indiana 46285. response to excitotoxic stress (Yang et al., 1997b). No
Immunity
576
Figure 1. Generation of JNK2-Deficient Mice
(A) The structure of the four murine JNK2 isoforms (JNK2a1, JNK2a2, JNK2b1, and JNK2b2). The alternative splicing of exons that encode
sub-domains IX and X (a and b isoforms) and at the COOH terminus (1 and 2 isoforms) is indicated.
(B) The amino acid sequence of mouse JNK2a2 deduced from the sequence of cDNA clones is presented. The alternative sequence of the
b isoforms (sub-domains IX and X) and the COOH terminus (1 isoforms) are indicated by the shaded boxes. (#) represents a termination
codon.
(C) Strategy for the disruption of the JNK2 gene by homologous recombination. The three hatched boxes are JNK2 exons corresponding to
subdomains VIII and IX (amino acid residues 151±229). The tripeptide motif Thr-Pro-Tyr (TPY) includes the dual phosphorylation sites characteris-
tic of the JNK group that is required for protein kinase activity. Restriction enzyme sites are indicated (B, BamHI; H, HpaI; M, MscI; N, NotI;
R, EcoRI; and X, XbaI).
change in T cell development and T cell activation was The construct pJNK2KO was transfected into D3 ES
cells (Figure 1C). Chimeras were generated by injectingobserved in these mice. To address the specific role of
the other JNK isoforms in the immune response, we these ES cells into C57BL/6 (B6) blastocysts. Heterozy-
gotes (1/2) were intercrossed to generate homozygoushave generated and studied JNK2-deficient mice. These
animals show normal T and B cell development and T mutant mice (2/2) that were identified by Southern blot
analysis of genomic DNA (Figure 2A). The expression ofcell proliferation. However, analysis of the differentiation
of precursor T cells into effector T cells revealed an the endogenous JNK2 gene was examined by reverse
transcriptase (RT)-PCR using total RNA isolated fromimpairment in Th1 differentiation in the absence of JNK2.
The attenuation of Th1 responses was primarily due to the thymus. JNK2 mRNA was not detected in homozy-
gous JNK22/2 mice (Figure 2B).reduced IL-12-stimulated IFNg secretion by CD41 T cells
at early stages of the differentiation process. Thus, the The expression of JNK2 protein was examined by
Western blot analysis of brain, thymocytes, and T cellsJNK pathway plays a critical role in the balance of Th1
and Th2 responses. from wild-type (WT) and JNK2-deficient mice. As ex-
pected, JNK2 proteins were not detected in the JNK22/2
mice (Figure 2C). The major JNK2 proteins observedResults
in wild-type tissue correspond to the 55 kDa isoforms
(Figure 2C).Generation of JNK2-Deficient Mice
Three JNK genes have been identified in mammalian cells, Together, these data demonstrated that the disrupted
JNK2 gene was a null allele and that homozygous JNK2JNK1, JNK2, and JNK3 (Whitmarsh and Davis, 1996; Ip
and Davis, 1998). In addition, several isoforms generated (2/2) mice were defective in JNK2 expression.
by alternative splicing of transcripts derived from these
genes have been identified in humans (Gupta et al., 1996). Normal T and B Cell Development
No obvious abnormalities were detected in the tissuesWe have now identified four murine JNK2 isoforms:
JNK2 a1, a2, b1, and b2 (Figure 1A). These isoforms have that were examined histologically (e.g., brain, liver, and
bone) in JNK22/2 mice. To determine the role of JNK2alternative sequences within protein kinase subdomains
IX and X (a and b isoforms) and alternative COOH termini in thymic T cell development, we first examined the
distribution of the different thymocyte subpopulations.(1 and 2 isoforms) (Figure 1B). To determine the specific
role of JNK2 in the immune response, we generated No differences in the percentage of immature double
negative CD42CD8, double positive CD41CD81, or ma-mice deficient in the four isoforms of JNK2. The deleted
region encompasses three exons corresponding to the ture single positive CD41 and CD81 cells between
JNK22/2 and wild-type mice were observed (Figure 3A).encoded protein subdomain VIII and the two alterna-
tively spliced a and b exons (Figure 1C). Analysis of other differentiation markers (TCR, CD69,
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Figure 2. Identification of the Targeted Disruption of the Murine
JNK2 Gene
(A) Genomic DNA indicates the presence of all three expected geno-
types. EcoRI restricted DNA from wild-type (1/1), heterozygous
(1/2), and homozygous (2/2) JNK2-deficient mice was probed
with the radiolabeled probe A (Figure 1). The upper band (8.5 kb)
corresponds to the wild-type allele (JNK21) and the lower band (6.0
kb) corresponds to the mutant allele (JNK22).
(B) Total RNA was isolated from wild-type (1/1), heterozygous
(1/2), and homozygous (2/2) knockout mice, and the JNK2 gene
and HPRT gene were amplified by RT-PCR.
(C) Western blot analysis of brain, thymus, and CD41 T cell lysates
from wild-type (1/1) and homozygous knockout (2/2) mice. The
blots were probed with an antibody to JNK. The bands detected at
46 kDa and 55 kDa correspond to differentially spliced isoforms of
JNK1 and JNK2.
CD44, CD25, and heat stable antigen) that characterize
Figure 3. T and B Cell Development Is Similar in Wild-Type andthe maturation stage of each population showed no
JNK22/2 Mice
differences between JNK22/2 and wild-type thymocytes
Thymocytes (A) or splenocytes (B) from wild-type (WT) and JNK22/2
(data not shown). mice were isolated and stained for CD4 and CD8 and analyzed by
The ratio of CD41 and CD81 mature T cells in the flow cytometry. (C) Total lymph node cells were isolated from WT
spleen was similar in both groups of mice (Figure 3B). and JNK22/2 mice and stained with anti-CD3 and anti-CD45R/B220
MAbs. (D) Total spleen cells were stimulated with ConA, PMA (5In addition, no differences in the percentage of periph-
ng/ml) plus ionomycin (250 ng/ml) (P/I), or medium alone (2). Theeral B cells in JNK22/2 mice were observed (Figure 3C).
proliferative response was analyzed by [3H]thymidine incorporationAnalysis of TCR expression in T cells indicated normal
after 3 days. The average of three independent experiments is pre-
maturation of these cells during thymic development sented. (E) Total spleen cells were stimulated as described in (D).
(data not shown). Supernatants were collected 24 hr following stimulation and as-
TCR ligation, in combination with the CD28-mediated sayed for IL-2 production.
signal, has been reported to induce JNK activity in Jurkat
cells (Su et al., 1994). To determine the contribution of
JNK2 to T cell activation, we examined the proliferative In addition, the cytokine environment is one of the major
factors that directs differentiation into Th1 or Th2 cells.response of spleen cells from JNK22/2 and wild-type
mice. Only marginal differences were observed in the It has been reported that JNK activity is regulated by
several cytokines, suggesting that JNK may be involvedresponse to Concanavalin A (ConA), a polyclonal T cell
stimulator, or phorbol myristate acetate (PMA) plus iono- in the differentiation and/or activation of effector CD41
Th1 and Th2 cells. We showed recently that JNK ismycin, indicating that T cell proliferation occurred nor-
mally in the absence of JNK2 (Figure 3D). In correlation, activated in precursor CD41 T cells upon antigen stimu-
lation (RincoÂ n et al., 1997b), although 24 hr was requiredthe levels of IL-2 (a major growth factor of T cells) pro-
duced by spleen cells upon activation were similar in to detect significant activity. However, following differ-
entiation of these cells into effector CD41 Th2 cells,JNK22/2 and wild-type mice (Figure 3E).
antigen stimulation did not upregulate JNK activity and
slightly inhibited the basal JNK activity levels (RincoÂ nReduced JNK Activity and Increased AP-1
Transcriptional Activity in JNK22/2 et al., 1997b). To examine the regulation of JNK in Th1
cells, we first isolated CD41 T cells from spleen andCD41 Th1 Cells
Precursor CD41 T cells differentiate into effector Th1 or lymph nodes from wild-type mice. These cells were dif-
ferentiated into effector Th1 and Th2 cells by activationTh2 cells that secrete high levels of specific cytokines.
Immunity
578
Figure 4. Endogenous JNK Activity and AP1 Transcriptional Activity Are Inversely Related in Th1 Cells from Wild-Type and JNK22/2 Mice
(A) CD41 T cells were stimulated with ConA, in the presence of APC, and exogenous IL-4 (Th2) or IL-12 (Th1) for 4 days. At day 4, the
differentiated Th1 and Th2 cells (5 3 105 cells) were harvested, exhaustively washed, and restimulated with PMA (5 ng/ml) and ionomycin
(250 ng/ml). Cells were then harvested and lysed at 0, 30, and 60 min, and cell extracts were assayed for JNK activity. Phosphorylated GST-
c-Jun was detected after SDS-PAGE by autoradiography and quantified by PhosphoImager analysis.
(B) Th1 and Th2 CD41 T cells differentiated for 4 days as described in (A) were lysed, and cell extracts were assayed for JNK protein levels
by Western blot analysis.
(C and D) Th1 and Th2 CD41 T cells differentiated as described in (A) were restimulated (5 3 105 cells) with ConA (C) or immobilized anti-
CD3 MAb (D) for different time periods. Cell extracts were assayed for JNK activity as described in (A).
(E) Th1 and Th2 cells (5 3 105 cells) from JNK21/2 3 AP1-luciferase and JNK22/2 3 AP1-luciferase transgenic mice differentiated as described
in (A) were restimulated with ConA for 10 and 24 hr, harvested, and assayed for luciferase activity.
with ConA in combination with IL-12 (Th1 differentiation) from wild-type mice (Figures 4C and 4D). In contrast,
the levels of JNK activity induced in Th1 cells fromor IL-4 (Th2 differentiation) in the presence of APC (Ka-
mogawa et al., 1993; RincoÂ n et al., 1997a, 1997b). After JNK22/2 mice were significantly lower (Figures 4C and
4D). In addition, stimulation with ConA or anti-CD3 MAb4 days of differentiation, the cells were washed and
counted and equal numbers of cells were restimulated failed to upregulate JNK activity in Th2 cells from either
wild-type or JNK22/2 mice (Figures 4C and 4D). Thesewith PMA plus ionomycin, a TCR-independent stimulus,
in the absence of exogenous cytokines and APC. JNK results showed that regulation of JNK MAP kinase path-
way differs profoundly in Th1 and Th2 cells.activity was not upregulated in Th2 cells (Figure 4A). In
contrast, rapid induction of JNK activity was observed c-Jun is one component of AP-1 transcription factor
complexes. JNK activates c-Jun-mediated transcriptionin Th1 cells upon PMA plus ionomycin stimulation (Fig-
ure 4A). The levels of JNK1 and JNK2 proteins, however, by phosphorylation of the transactivation domain (Whit-
marsh and Davis, 1996; Ip and Davis, 1998). We havewere similar in both subsets of cells (Figure 4B), indicat-
ing that JNK protein expression was not the major cause previously shown that AP-1 transcriptional activity is
highly induced in Th2 cells upon antigen stimulationof the selective induction of JNK activity in Th1 cells.
We therefore examined JNK activity in Th1 and Th2 cells but poorly induced in Th1 cells (RincoÂ n et al., 1997b).
However, the data described above indicated that ConAin response to TCR-dependent stimulation in JNK22/2
mice. CD41 T cells isolated from wild-type or JNK22/2 activated JNK in Th1 cells but not in Th2 cells, sug-
gesting that the AP-1 transcriptional activity induced inmice were differentiated into Th1 and Th2 cells with
ConA. After 4 days, the cells were washed and restimu- Th2 cells may be independent of JNK and/or that JNK
may negatively regulate AP-1 in effector CD41 T cells.lated with ConA (Figure 4C) or immobilized anti-CD3
MAb (Figure 4D). Both ConA and anti-CD3 MAb stimula- Previous studies have demonstrated that AP-1 tran-
scriptional activity can be regulated by JNK-dependenttion induced JNK activity in Th1 cells but not in Th2 cells
Th1 Differentiation Requires JNK2
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Figure 5. Analysis of the Cytokines Produced in Effector Th1 and Th2 Cells from Wild-Type and JNK22/2 Mice
(A) FACS profiles represent the CD44 and CD45RB expression in gated CD41 T cells. Upper gate (CD41CD44highCD45RBlow) represents memory
cells and lower gate (CD44lowCD45RBhigh) represents naive CD41 T cells.
(B) Th1 and Th2 cells differentiated as described in Figure 4A were restimulated with ConA for 24 hr. Cytokine levels were determined by
ELISA.
(C) Cytokine levels produced by Th1 and Th2 cells after restimulation with ConA were determined by ELISA. Values represent average
percentages (n 5 6) of cytokine produced (IL-4 or IFNg) by JNK22/2 mice versus WT mice.
(D) CD41 T cells were stimulated with Con A and APC in the absence of exogenous IL-4 or IL-12 for 4 days and restimulated with Con A for
24 hr. Cytokine levels were determined by ELISA.
(E) CD41 T cells were stimulated with immobilized anti-CD3 MAb (5 mg/ml) or immobilized anti-TCR MAb (10 mg/ml) in the presence or absence
of soluble anti-CD28 MAb (1 mg/ml). At day 4, the cells were restimulated with immobilized anti-CD3 MAb (5 mg/ml) or anti-TCR MAb (10 mg/
ml) alone for 24 hr. Cytokine levels were determined by ELISA.
and JNK-independent pathways (Yang et al., 1997a). We JNK activity in Th1 cells led to increased rather than
decreased AP-1 transcriptional activity in Th1 cells.therefore examined AP-1 transcriptional activity in Th1
and Th2 cells from both wild-type and JNK2-deficient Together, these data suggest that JNK may play a
role in the activation of effector Th1 cells but may notmice. JNK22/2 mice were crossed with AP-1 luciferase
reporter transgenic (AP1-luc) mice described previously be required for effector Th2 cells. We therefore exam-
ined the function of JNK2 on cytokine production in(RincoÂ n and Flavell, 1994; RincoÂ n et al., 1997b). CD41
effector Th1 and Th2 cells.T cells from the JNK22/2 3 AP1-luc and JNK22/1 3 AP1-
luc mice were isolated and differentiated into Th1 and
Th2 cells, as described above. Heterozygous JNK22/1 IFNg Production Is Impaired in Th1 Cells
mice were used as the control to eliminate possible from JNK2-Deficient Mice
differences due to genetic background. After differentia- CD41 T cells from wild-type and JNK22/2 mice were
tion, Th1 and Th2 cells were washed, and an equal num- isolated and activated with ConA and wild-type APC in
ber of each cell type was restimulated with ConA for 10 the presence of IL-4 or IL-12. Analysis of cell surface
or 20 hr prior to measurement of luciferase activity. As markers on unstimulated CD41 T cells by flow cytometry
previously described (RincoÂ n et al., 1997b), AP-1 tran- failed to demonstrate differences in the presence of
scriptional activity in Th1 cells was significantly lower naive (CD41 CD45RBhigh CD44low) and memory (CD41
than in Th2 cells from control JNK22/1 3 AP1-luc mice CD45RBlow CD44high) populations between wild-type and
(Figure 4E). In contrast, the levels of AP-1 transcriptional JNK22/2 CD41 T cells (Figure 5A). After 4 days of differ-
activity were similar in both Th1 and Th2 cells from entiation the cells were washed and equal numbers of
cells were restimulated with ConA alone. SupernatantsJNK22/2 3 AP1-luc mice (Figure 4E). Thus, the lack of
Immunity
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Figure 6. Expression of IFNg in Effector Th1
and Th2 Cells from Wild-Type and JNK22/2
Mice
(A) Th1 and Th2 cells differentiated as de-
scribed in Figure 4A were restimulated with
Con A. Twenty-four hours after restimulation
IFNg and HPRT mRNA expression was deter-
mined in the presence of competitor (200 fg/
ml) by competitive RT-PCR as described in
Experimental Procedures.
(B) Th1 cells were restimulated with Con A
for 24 hr, fixed, permeabilized, and stained
with anti-CD4 and anti-IFNg MAbs, and ana-
lyzed by flow cytometry. The dotted line in
the histogram represents the negative control
and the solid line represents the anti-IFNg
MAb staining in gated CD41 cells. Values rep-
resent the percentage (%) and the mean fluo-
rescence intensity (MFI) of the cells express-
ing low (Lo) or high (Hi) levels of IFNg.
were harvested after 24 hr and analyzed for cytokine CD41 T cells from wild-type and JNK22/2 mice were
unable to produce significant amounts of IFNg. CD41 Tsecretion. No differences in the production of IL-4 in
effector Th2 cells from JNK22/2 and wild-type mice were cells from wild-type mice that have been differentiated
with ConA alone produced significant amounts of IL-4observed (Figure 5B). In contrast, IFNg production was
significantly reduced in effector Th1 cells from JNK22/2 after restimulation (Figure 5D). The production of IL-4
in these conditions was increased in JNK22/2 CD41 Tmice compared with wild-type Th1 cells (Figure 5B). The
impairment of IFNg production in Th1 cells from JNK2- cells compared to that in wild-type CD41 T cells.
We also analyzed the cytokine profile in cells differen-deficient mice was consistent in several independent
experiments (Figure 5C), suggesting that JNK2 is re- tiated with other T cell stimuli. CD41 T cells from wild-
type or JNK22/2 mice were activated with immobilizedquired for the activation of Th1 but not Th2 cells. The
number of JNK22/2 Th1 cells obtained after differentia- anti-CD3 MAb for 4 days, washed, and restimulated for
24 hr. In contrast to ConA differentiation (Figure 5D),tion in vitro from the same initial number of naive T cells
was slightly higher than wild-type Th1 cells (data not CD41 T cells from wild-type mice differentiated with
anti-CD3 MAb in the absence of polarizing cytokinesshown), indicating that the IFNg defect was not caused
by increased cell death. In addition, the reduction of produced high amounts of IFNg but undetectable levels
of IL-4 (Figure 5E). However, the production of IFNg wasIFNg production in Th1 cells from JNK22/2 mice was
associated with increased levels of secreted IL-4 (Figure significantly decreased in JNK22/2 CD41 T cells (Figure
5E). IFNg production was also reduced in JNK22/2 CD415B), consistent with the specific impairment of IL-12-
driven Th1 differentiation in these mice. T cells differentiated with anti-CD3 or anti-TCRb chain
MAb in the presence of anti-CD28, although to a lowerThe presence of IL-4 or IL-12 drives differentiation of
precursor CD41 T cells into effector Th2 or Th1 cells extent (Figure 5E). Together, these results suggested
that differentiation of CD41 T cells into Th1 cells is im-that produce high amounts of IL-4 or IFNg, respectively.
In the absence of a polarizing cytokine, the cells develop paired in the absence of JNK2.
It was possible that the diminished IFNg productioninto a Th0-like population that produces low levels of
both IL-4 and IFNg. To determine the Th-phenotype of in Th1 cells was caused by defective transcription of
the IFNg gene in JNK22/2 mice. Thus, we examined IFNgCD41 T cells in the JNK22/2 mice under neutral condi-
tions, CD41 T cells were differentiated with ConA and gene expression by competitive reverse transcriptase
(RT)-PCR in effector Th1 cells that were differentiatedAPC in the absence of added cytokines. After 4 days
the cells were restimulated with ConA for 24 hr. In the in the presence of IL-12. IFNg gene expression was not
detected in unstimulated effector Th1 or Th2 cells (dataabsence of polarizing cytokines, ConA-differentiated
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not shown) or in activated effector Th2 cells (Figure 6A) wild-type or JNK22/2 CD41 T cells during differentiation
in the presence of IL-4 (Figure 7B). Moreover, lower IFNgfrom JNK22/2 or wild-type mice. High levels of IFNg
mRNA were, however, induced in wild-type effector Th1 expression was observed in JNK22/2 CD41 T cells after
4 days of stimulation in the presence of exogenous IL-cells upon ConA activation (Figure 6A). These levels of
IFNg mRNA were substantially reduced in activated Th1 12 (Figure 7A).
These results indicated that precursor CD41 T cellscells from JNK2-deficient mice (Figure 6A). These data
indicate a role for JNK2 in the transcription of the IFNg from JNK22/2 mice failed to produce high levels of IFNg
in response to IL-12. It has been demonstrated thatgene by Th1 cells.
To determine whether IFNg production was sup- differentiation of precursor cells into effector Th1 cells
requires both IL-12 and IFNg (Bradley et al., 1996; Wen-pressed in most of the JNK22/2 Th1 cells or whether
this suppression was restricted to a subpopulation of ner et al., 1996). Thus, the lack of IFNg during the activa-
tion of JNK22/2 precursor CD41 T cells could be respon-Th1 cells, we examined the production of IFNg in individ-
ual cells by intracellular staining with a monoclonal anti- sible for their incomplete differentiation into effector Th1
cells even in the presence of exogenous IL-12. To ad-body to IFNg and flow cytometry. After 4 days of differ-
entiation, effector Th1 cells from JNK22/2 and wild-type dress this mechanism, we examined the cytokine pro-
file in Th1 cells differentiated in the presence of bothmice were activated with ConA for 24 hr and analyzed.
Although the percentage of cells producing low levels exogenous IL-12 and IFNg. CD41 T cells from JNK22/2
and wild-type mice were differentiated with ConA inof IFNg was similar in both wild-type and JNK22/2 mice,
the number of cells producing high levels of IFNg was the presence of IL-12 alone or IL-12 plus IFNg. After
4 days, cells were restimulated with ConA alone, andreduced in JNK22/2 mice (Figure 6B). These results indi-
cated that even in the presence of IL-12, JNK22/2 precur- supernatants were harvested after 24 hr. Less IFNg was
secreted by effector JNK22/2 Th1 cells than by wild-sor CD41 T cells failed to differentiate into Th1 cells
producing large amounts of the effector cytokine IFNg. type Th1 cells differentiated in the presence of IL-12
(Figure 7C). In contrast, similar levels of IFNg were pro-
duced in JNK22/2 and wild-type Th1 cells differentiated
Requirement of JNK2 for the Initiation in the presence of IL-12 and exogenous IFNg (Figure 7C).
of Th1 Differentiation Moreover, the production of IL-4 detected in JNK22/2 Th1
The inhibition of activation-induced IFNg production in cells was significantly reduced if exogenous IFNg was
differentiated effector Th1 cells from JNK22/2 mice sug- also present during the differentiation. Thus, the addition
gested that JNK2 is required for the expression of IFNg of exogenous IFNg corrects the defect in IL-12-stimu-
in committed effector Th1 cells, or alternatively that the lated Th1 cell differentiation caused by JNK2 deficiency.
differentiation of precursor CD41 T cells into effector These data indicate that the impairment of IFNg produc-
Th1 cells was inhibited in JNK22/2 mice. The latter mech- tion in Th1 cells from JNK22/2 mice was caused by
anism would imply that effector Th1 cells would not be inefficient IL-12 -stimulated differentiation of the precur-
fully differentiated in the presence of IL-12. sor CD41 T cells into armed effector Th1 cells.
IL-4 promotes differentiation of precursor CD41 T cells The IL-12 receptor consists of two components, IL-
into Th2 cells. In addition, IL-4 also inhibits the differenti- 12R b1 and the signal transducer IL-12R b2. Neither of
ation of Th1 cells by IL-12 (Le Gros et al., 1990; Swain these receptor components are expressed in precursor
et al., 1990; Hsieh et al., 1993; Seder et al., 1993). An CD41 T cells, but they are induced upon antigen stimula-
overproduction of endogenous IL-4 in precursor CD41 tion (Presky et al., 1996; Rogge et al., 1997; Szabo et
T cells from JNK22/2 mice, therefore, could cause defi- al., 1997). IL-12R b2 expression is downregulated rapidly
cient Th1 differentiation. However, no detectable levels during IL-4-driven differentiation of Th2 cells. In con-
of secreted IL-4 were found in supernatants during the trast, IL-12R b2 expression is highly upregulated during
differentiation of Th1 cells from wild-type or JNK22/2 differentiation of Th1 cells in the presence of IFNg (Szabo
mice (data not shown). We therefore examined the ex- et al., 1997). The lack of expression of the IL-12R b2
pression of the IL-4 gene in CD41 T cells after 4 days would result in the inability of IL-12 to drive Th1 differen-
of differentiation in the presence of ConA and IL-12. tiation. We therefore examined the expression of the IL-
Similar levels of IL-4 mRNA were detected in both wild- 12R b2 gene in Th1 cells from wild-type and JNK22/2
type and JNK22/2 CD41 T cells (Figure 7A), suggesting by semiquantitative RT-PCR. Interestingly, in correlation
that IL-4 overproduction was not the cause of the inhibi- with the deficient production of IFNg, the level of IL-12R
tion of Th1 differentiation in JNK22/2 mice. b2 gene expression was substantially reduced in Th1
Only low levels of IFNg are produced during the differ- cells from JNK22/2 mice, compared to wild-type Th1
entiation of CD41 T cells in the absence of exogenous cells (Figure 7D).
cytokine. However, the presence of exogenous IL-12
promotes Th1 differentiation, in part, by increasing IFNg
production. IFNg can both promote Th1 and inhibit Th2 Discussion
differentiation (Swain, 1995). We therefore also exam-
ined the production of IFNg during the differentiation of The decision of naive CD41 T cells to become effector
Th1 or Th2 cells determines the direction of an immuneprecursor CD41 cells from wild-type and JNK22/2 mice
activated with ConA in the presence of IL-12. The levels response. It is therefore essential to understand the spe-
cific intracellular signals that control the initiation of theof IFNg increased with time in wild-type CD41 T cells,
but IFNg did not increase in JNK22/2 CD41 T cells (Figure differentiation of precursor CD41 T cells into effector
Th1 and Th2 cells and the activation of these effector7B). No significant amounts of IFNg were detected in
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Figure 7. Cytokine Gene Expression in Differentiating Th1 Cells in Wild-Type and JNK22/2 Mice
(A) CD41 cells were stimulated with Con A in the presence of APC and exogenous IL-12. After 4 days, IFNg, IL-4, and HPRT gene expression
was determined by competitive RT-PCR in the presence of competitor, 100 fg/ml, 33 fg/ml, and 400 fg/ml, respectively.
(B) CD41 cells were stimulated with ConA in the presence of APC and IL-12 as described in (A). Supernatants were taken at different time
points during the differentiation, and IFNg levels were determined by ELISA.
(C) CD41 cells were differentiated with Con A in the presence of APC and exogenous IL-4, IL-12, or IL-12 plus IFNg (200 U/ml) for 4 days and
restimulated with Con A for 24 hr. Cytokine levels were determined by ELISA.
(D) CD41 cells were stimulated with Con A in the presence of APC and IL-12. At day 4, IL-12Rb2 and HPRT gene expression was determined
by semiquantitative RT-PCR.
cells. In this study, we demonstrate the role of a distinct activation of AP-1 transcriptional activity (RincoÂ n and
Flavell, 1994). No significant differences in IL-2 produc-JNK MAP kinase signaling pathway in controlling the
initiation of Th1 responses. tion and the proliferative response of T cells were ob-
served. However, the recovery of Th1 and Th2 cells uponThree genes encoding members of the JNK family,
JNK1, JNK2, and JNK3, and several alternatively spliced differentiation with ConA in the presence of IL-4 or IL-
12 was slightly higher in JNK22/2 mice than in wild-typemRNAs for each gene have been identified (Gupta et
al., 1996). These JNK isoforms differ in their interaction mice (data not shown). JNK has been associated with
the regulation of apoptosis in different cell systemswith specific substrates, such as c-Jun, Elk-1, and
ATF-2. The relative contribution of each of these iso- (Whitmarsh and Davis, 1996; Ip and Davis, 1998). Re-
cently, we have shown that the lack of JNK3 in vivoforms in the control of cellular responses is not yet
known. JNK3 is predominantly expressed in brain, heart, results in a deficiency in hippocampal neuronal cell
death in response to excitotoxic stress (Yang et al.,and testis (Yang et al., 1997b). The JNK1 and JNK2
genes are expressed ubiquitously and may have partially 1997b). Thus, it is possible that the lack of JNK2 causes
increased survival of CD41 T cells. Consistent with theseredundant functions (Whitmarsh and Davis, 1996; Ip and
Davis, 1998). Here, we demonstrate that JNK1 and JNK2 observations, the absence of one of the upstream acti-
vators of JNK, MKK4, in Rag22/2 chimeric mice causeddo not have redundant functions in T cells. This suggests
that JNK1 and JNK2 may play different roles in the con- lymphoadenopathy (Swat et al., 1998).
The examination of JNK-deficient mice has revealedtrol of cell growth, differentiation, and death.
Several studies have examined the regulation of JNK a role of JNK2 in Th1 and Th2 responses. JNK2 is re-
quired for the production of IFNg in Th1 cells but notactivity during the activation of T cells. JNK activation
has been shown to require both protein kinase C activa- for IL-4 production in Th2 cells. We have shown that IL-
12 fails to induce high levels of IFNg during the differenti-tion (e.g., phorbol ester) and a calcium signal (Su et al.,
1994). Moreover, in addition to TCR-mediated signals, ation of precursor CD41 T cells in JNK22/2 mice. Supple-
mentation with exogenous IFNg during differentiation ininduction of JNK appears to require signals provided
by costimulatory molecules (Su et al., 1994). These sig- the presence of IL-12 rescues the phenotype, and the
JNK22/2 Th1 cells develop normally. Together, thesenaling requirements correlate with those needed for the
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results indicate that diminished production of IFNg in and AP-1 transcriptional activity in effector CD41 T cells.
JNK activity, but not AP-1 transcriptional activity, caneffector Th1 cells upon antigen stimulation observed in
JNK22/2 mice is due to impaired Th1 differentiation. be significantly induced in Th1 cells upon ConA-stimula-
tion, while AP-1 transcriptional activity, but not JNK ac-JNK, however, does not appear to be directly involved
in the IL-12 signaling pathway, since JNK activity was tivity, is induced in Th2 cells. Paradoxically, in the ab-
sence of JNK2, AP-1 transcriptional activity is increasednot upregulated by IL-12 in activated CD41 T cells (data
not shown). in Th1 cells. JNK activation may therefore inhibit AP-1-
mediated transcription in Th1 cells. Alternatively, theThe relative contributions of IL-12 and IFNg in Th1
differentiation is controversial (Seder and Paul, 1994; induction of AP-1 transcriptional activity in Th1 cells
from JNK22/2 mice may result from incomplete differen-Trinchieri, 1995). It is generally believed that both cyto-
kines are required for the complete differentiation of Th1 tiation to the Th1 phenotype, a hypothesis that is consis-
tent with the results of this study.cells. Although IFNg alone is not sufficient to differenti-
ate CD41 T cells into effector Th1 cells, the presence The upregulation of JNK activity in Th1 cells despite
the low induction of AP-1 transcriptional activity sug-of endogenously synthesized IFNg during the priming
of naive CD41 T cells both accelerates and enhances gests that substrates other than AP-1 can be phosphory-
lated by JNK in Th1 cells upon activation. The transcrip-the Th1-differentiating effects of IL-12 (Bradley et al.,
1996; Wenner et al., 1996). IFNg induces early induction tion factor ATF-2 can also be phosphorylated and
activated by JNK (Gupta et al., 1995). ATF/CREB bindingof IL-12 production in macrophages and monocytes
(Trinchieri, 1995). Thus, decreased levels of endogenous sites have been characterized in the promoter region of
the IFNg gene (Penix et al., 1993, 1996). However, theIFNg during differentiation could cause a reduction of
IL-12 production by APC. This is unlikely to explain our specific contribution of these elements in the control of
IFNg gene transcription remains unclear. Recently, itresults since even in the presence of large amounts of
exogenous IL-12, Th1 cells do not differentiate properly has been reported that JNK can negatively regulate the
activation of specific transcription factors includingin JNK22/2 mice.
In addition to the IL-12R b1 subunit, a second compo- NFAT-4 (Chow et al., 1997). Thus, it is possible that
the selective activation of JNK in Th1 cells functions tonent of the IL-12 receptor, IL-12R b2, has recently been
cloned (Presky et al., 1996). Neither IL-12R b1 nor b2 is repress the transcription machinery that leads to the
expression of Th2 cell specific cytokine genes.expressed in precursor CD41 T cells, but their expres-
sion can be induced by TCR-mediated signals. However, Several transcription factors have been described to
play a selective role in Th1 or Th2 cells (RincoÂ n andunlike the b1 subunit, the signal-transducting b2 subunit
is tightly regulated during the differentiation of Th1 and Flavell, 1997). Stat-6, GATA-3, c-Maf, NFATc, AP-1, and
NF-IL6 all appear to positively control Th2 responses.Th2 cells. While low levels of IL-4 inhibit the expression
of IL-12R b2 gene expression, IFNg strongly upregulates In contrast, activation of Stat-4, IRF-1, and NFATp leads
to polarized Th1 responses. Although some of theseits expression and can override the IL-4-mediated inhibi-
tion (Szabo et al., 1997). We have found that the expres- transcription factors (e.g., GATA-3 and c-Maf) are selec-
tively expressed only in Th1 or Th2 cells, other transcrip-sion of the b2 subunit of IL-12R is reduced in JNK22/2
CD41 T cells in correlation with the low levels of IFNg tion factors are present in both cell types but mediate
transcription in only one cell type. Thus, the upstreamsecreted during differentiation. Thus, the lower level of
IFNg and the normal levels of IL-4 produced during the signaling pathways coupled to the activation or repres-
sion of transcription factors may be differentially regu-differentiation of Th1 cells in JNK22/2 mice could be
insufficient to induce the expression of the IL-12Rb2 lated. Recently, we have shown that the p38 MAP kinase
pathway is required for induced expression of IFNg inchain. This suggests that TCR-mediated IFNg produc-
tion in JNK22/2 precursor CD41 T cells is one of the effector Th1 cells but does not affect Th1 cell differentia-
tion (RincoÂ n et al., 1998). Here, we demonstrate that thecauses of the impaired Th1 differentiation. In correlation,
JNK22/2 CD41 T cells differentiated with anti-CD3 or JNK2 signaling pathway is required for the early initiation
of the differentiation of precursor CD41 T cells into ef-anti-TCR MAb in the absence of IL-12 also produce
lower levels of IFNg compared to those in wild-type fector Th1 cells.
CD41 T cells.
We have shown here that JNK activity is rapidly in- Experimental Procedures
duced in Th1 effector cells but not in Th2 cells, even in
Gene Targeting and Generation of JNK22/2 Miceresponse to the TCR-independent stimulus PMA plus
We isolated four JNK2 cDNAs from a murine brain library (l ZAPIIionomycin. The addition of exogenous IL-4 during Th1
vector; Stratagene Inc.). These cDNAs correspond to the JNK2a1,cell activation did not abrogate the upregulation of JNK
JNK2a2, JNK2b1, and JNK2b2 isoforms identified previously in hu-
activity (data not shown), suggesting that IL-4 does not mans (Gupta et al., 1996). The sequence of the murine JNK2 cDNAs
inhibit JNK activation in Th2 cells. The mechanisms that has been deposited in GenBank with accession numbers AF052466,
mediate this selective activation of JNK in Th1 cells, AF052467, AF052468, and AF052469. JNK2 genomic clones were
isolated from a mouse strain 129/Sv library (l FixII vector, Stra-however, need to be determined, as it was not caused by
tagene, Inc.). A 8.4 kb NotI±XbaI genomic DNA fragment corre-a difference in the expression level of the JNK proteins.
sponding to JNK2 was identified. The internal 2.5 kb HpaI±MscIMoreover, the role of JNK in Th1 cells remains unclear.
fragment was deleted and replaced with a 1.6 kb PGK-neo cassettec-Jun, one component of AP-1 complexes, is phosphor-
(Yang et al., 1997a). A 2.6 kb PGK tk cassette (Yang et al., 1997a)
ylated and activated by JNK (Whitmarsh and Davis, was added to the 39 end of the NotI±XbaI JNK2 genomic fragment.
1996; Ip and Davis, 1998). Surprisingly, however, we The resulting targeting vector pJNK2KO was linearized with NotI
and electroporated into D3 ES cells, provided by Dr. T. Doetschman.have found an inverse correlation between JNK activity
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Genomic DNA from transfectants resistant to G418 (200 mg/ml) determined by RT-PCR using serial dilutions (1:1, 1:10, and 1:1:00)
of the reverse transcription mixture. The primers used for PCR of(GIBCO-BRL) and gancyclovir (2 mM) (Syntex, Palo Alto, CA) was
characterized by Southern blot analysis. The probe used was a 2.8 IL-12Rb2 were IL-12Rb2 A (59-GGCCCACTCCTGAAGAGCC-39) and
IL-12Rb2 B (59-CAGCCGCTCACCACCGAA-39).kb EcoRI±BamHI fragment of the JNK2 genomic sequence external
to the targeting construct that hybridizes to a 8.5 kb EcoRI fragment
of the endogenous JNK2 gene and to a 6.0 kb fragment of the Cytokine Production Measurement
targeted allele. ELISA assays were performed using purified anti-IL-4 and anti-IFNg
MAbs (2 mg/ml) as the primary antibody and the corresponding
Cell Preparation and Surface Staining biotinylated anti-IL-4, anti-IFNg MAbs (1 mg/ml) (Pharmingen), a
Total CD41 T cells were isolated from spleen and lymph nodes from horseradish peroxidase-conjugated avidin D (2.5 mg/ml) (Vector
wild-type or JNK2-deficient littermates by negative selection using Laboratories, Burlingame, CA) following the recommended protocol
anti-NK (NK1.1) (Pharmingen), anti-CD8 (Pharmingen), and anti- (Pharmingen). Recombinant IL-4 (DNAX) and IFNg (GIBCO-BRL)
MHC class II MAbs to deplete NK, CD8, and B cells, respectively were used as standards.
(Kamogawa et al., 1993; RincoÂ n et al., 1997a). Mitomycin C±treated
(50 mg/ml) syngeneic splenocytes from wild-type mice were used Western Blot Analysis
as a source of APC. CD41 T cells were cultured at 106 cells/ml in JNK protein levels were assayed by immunoblot analysis using a
the presence of syngeneic APC (5 3 105 cells/ml) with ConA (2.5 mg/ monoclonal anti-human JNK antibody (Pharmingen). Immune com-
ml) (Boehringer, Mannheim, Germany) plus IL-12 (3.5 ng/ml) (kindly plexes were detected by enhanced chemiluminescence as in-
provided by Genetics Institute, Cambridge, MA) or IL-4 (103 U/ml) structed by the manufacturer (Amersham Int. PLC).
(kindly provided by DNAX, Los Angeles, CA). After 4 days, effector
Th cells were exhaustively washed, counted, and restimulated at Protein Kinase Assays
106 cells/ml with ConA (2.5 mg/ml) in the absence of APC. CD41 T Protein kinase assays were performed as described (DeÂ rijard et al.,
cells were also cultured at 106 cells/ml in the presence of plastic- 1994). T cell lysates were incubated in Triton lysis buffer (20 mM
immobilized anti-CD3 (2C11) (5 mg/ml) or anti-TCRb MAb (H57) (10 Tris [pH 7.4], 1% Triton X-100, 10% glycerol, 137 mM NaCl, 2 mM
mg/ml) in the presence or absence of soluble anti-CD28 MAb (1 mg/ EDTA, 25 mM b-glycerophosphate, 1 mM sodium orthovanadate, 2
ml) (Pharmingen, San Diego, CA). After 4 days, effector Th cells mM pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, and 10 mg/
were exhaustively washed, counted, and restimulated at 106 cells/ ml leupeptin) with GST-c-Jun immobilized on GSH-agarose beads.
ml with either plastic-immobilized anti-CD3 (5 mg/ml) or anti-TCR After 12 hr at 4C, the beads were washed extensively in lysis buffer
(10 mg/ml) MAb alone. followed by kinase assay buffer (25 mM HEPES [pH 7.4], 25 mM
A red613-conjugated anti-CD4 MAb, a fluorescein isothiocyanate-
b-glycerophosphate, 25 mM MgCl2, 0.1 mM sodium orthovanadate,conjugated (FITC)-anti-CD8 MAb, a FITC-anti-CD45R/B220 MAb, and 0.5 mM DTT), and the activity of the bound JNK was detected
and a phycoerythrin-conjugated (PE)-anti-CD3 MAb (Pharmingen) by the addition of [g-32P] ATP for 30 min at 308C. The reaction
were used to determine the cell populations present in the thymus, products were resolved by SDS-PAGE and the incorporation of [32P]
spleen, and lymph nodes by cell surface staining and flow cytometry phosphate was quantitated by Phosphorimager analysis (Molecular
(EPIC, Coulter). The distribution of naive and memory CD41 T cells Dynamics).
was performed by cell surface staining with a red613-anti-CD4 MAb,
PE-anti-CD44 MAb, and a FITC-anti-CD45RB MAb (Pharmingen).
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